氧化释放动力学对抗真菌活性的影响
Quincy E Grayton1, Ivie L Conlon1, Christopher A Broberg1
1Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Journal of fungi (Basel, Switzerland)
|May 24, 2024
概括
氧化 (NO) 具有广泛的抗真菌活性,可以对抗抗性真菌,如Candida和Aspergillus. 具有更快释放动力学的NO供体显示出与现有的抗真菌药物增强的疗效和兼容性.
科学领域:
- 发现抗微生物药物发现.
- 菌类学 菌类学是指菌类学.
- 药品化学 药品化学 是一个
背景情况:
- 致病性真菌中药物耐药性的增加构成了全球健康的重大挑战.
- 有限的抗真菌选择和越来越多的抗药性导致医疗保健成本上升,患者的生活质量下降.
- 氧化 (NO) 已显示出抗菌潜力,但其对真菌病原体的特定影响需要进一步阐明.
研究的目的:
- 为了研究释放氧化 (NO) 的小分子的广谱抗真菌活性.
- 评估NO释放动力学对对关键病原菌的抗真菌功效的影响.
- 评估NO供体与现有抗真菌疗法的兼容性.
主要方法:
- 对四种释放氧化的小分子进行了测试,对抗 *Candida albicans*, *Candida auris*, *Cryptococcus neoformans* 和 *Aspergillus fumigatus*.
- 在24小时暴露于一剂量NO的玻尿酸剂后,评估了抗真菌作用.
- 确定了NO捐赠者半衰期,有效度和选择性指数之间的关系.
- 检查了处理后的真菌表面形态.
- 评估了NO供体与常规抗真菌药物的协同作用潜力.
主要成果:
- 一次剂量NO在24小时内根除了测试的真菌物种.
- 半衰期较短的NO捐赠者在较低度下表现出强烈的抗真菌活性,表现出更广泛的选择性指数.
- 所有测试的NO供体都诱导了真菌细胞的显著表面破坏.
- 所有的NO捐赠体都与目前针对各种真菌物种的处方抗真菌药物相兼容.
结论:
- 氧化对临床相关的病原菌具有广泛的疗效.
- 无氧化物捐赠者的受控释放动力学对于优化抗真菌功效和安全至关重要.
- 释放NO的分子是一个有前途的治疗策略,可能增强现有的抗真菌治疗.
相关概念视频
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
807
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
807
Antianginal Drugs: Nitrates and β-Blockers
575
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
575
Antihypertensive Drugs: Vasodilators
505
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
505
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K


